Proceedings.

Novelion Therapeutics Inc.

Follow
Closed
Proceeding
Winding-up (provincial)sections 105(a) and 1521 of the Bankruptcy Code
File
S1913050
Filings held43
Last activity24 Jul 2026
On the record1,851 days
Claims processIf you are owed money

A claims procedure has been established — see the order for deadlines.

Per the Claims Process Order made January 9, 2020 dated 9 January 2020.

Proceedings AIAsk this case — answers cite the filings
Ask in plain language. The answer comes only from this case’s filings, each one cited.
Enter to send · Shift+Enter for a new line
Case updates38 dated entries · 5 undated

35 earlier updates, back to 27 August 2021 subscribers.

Undated filings5 — no date appears on the document · show

5 filings carry no date on their face — subscribers.

Parties

Debtor

Novelion Therapeutics Inc.

Liquidator

Alvarez & Marsal

RecoveriesAs declared or paid

Equity: a distribution.FinalFourth Report of the Liquidator · 6 Jul 2026

ClassCreditorClaimsRecoveryBasisSource
Equityregistered shareholdersa distributionfinalFinalper the liquidatorFourth Report of the Liquidator · 6 Jul 2026

Each row is one filing's statement, copied as it reads and never computed. "Estimated" is the officer's forecast; "Under the plan" is the plan's or proposal's own term; "Final" is a declared or paid distribution; a row with no chip states no footing. A range is the two numbers stated; "of proven claims" is the document's own denominator.

2 stated figures across 1 outcome, each sourced

Subscribe

Already a subscriber? Sign in.

Fees and ratesAs stated in the filings

3 engagements · 3 firmslatest: Alvarez & Marsal Canada Inc., 9 Sep 2019 – 30 Jun 2021Third Report of the Liquidator · 29 Jul 2021

FirmPeriodHoursFeesRatesSource
Alvarez & Marsal Canada Inc.Liquidator9 Sep 2019 – 30 Jun 2021•••not statedThird Report of the Liquidator · 29 Jul 2021
Fasken Martineau DuMoulin LLPCounsel13 Nov 2019 – 30 Nov 2020•••not statedThird Report of the Liquidator · 29 Jul 2021
Norton Rose Fulbright Canada LLPCounsel2 Dec 2019 – 30 Jun 2021•••not statedThird Report of the Liquidator · 29 Jul 2021

12 stated figures across 3 engagements, each sourced

Subscribe

Already a subscriber? Sign in.

Documents
43 filings
DateDocumentFile
Order re. Discharge entered July 24, 2026PDF · Subscribers
Fourth Report of the Liquidator
  • Recovery outcome Entries: per actual · Stated on: 2026-07-06 · Table missing:
PDF · Subscribers
Notice of Application of LiquidatorPDF · Subscribers
Second Affidavit of Anthony TillmanPDF · Subscribers
Second Affidavit of Evan CobbPDF · Subscribers
Supplemental Certificate of ServicePDF · Subscribers
Certificate of ServicePDF · Subscribers
First Affidavit of Kibben Jackson made August 16, 2021PDF · Subscribers
First Affidavit of Evan Cobb made August 12, 2021PDF · Subscribers
First Affidavit of Anthony Tillman made August 9, 2021PDF · Subscribers
Notice of Application of Liquidator filed August 5, 2021PDF · Subscribers
Order Made After Application (ADR Disposition, Final Distribution, etc.)PDF · Subscribers
Third Report of the Liquidator
PDF · Subscribers
Notice of Hearing on Final Report and Petitioner’s MotionPDF · Subscribers
Notice of Hearing on Petitioner’s Motion for Ordering Enforcing the Final Distribution OrderPDF · Subscribers
Notice of Application of Liquidator returnable January 22, 2021PDF · Subscribers
Order Approving the Mati Transaction and the Retinagenix TransactionPDF · Subscribers
First Report of the LiquidatorPDF · Subscribers
Service List (November 9, 2020)PDF · Subscribers
Claims Process Notice
  • Financial position · Secured creditors · Unsecured creditors Subscribers
PDF · Subscribers
Claims Process Order made January 9, 2020PDF · Subscribers
First Affidavit of Scott Boucher made January 9, 2020PDF · Subscribers
Liquidation Order made January 9, 2020PDF · Subscribers
Second Affidavit of Michael Price made January 9, 2020PDF · Subscribers
Second Report of the LiquidatorPDF · Subscribers
Corp. Ownership StatementPDF · Subscribers
1007 ListPDF · Subscribers
Memo of LawPDF · Subscribers
Petition to the Court filed November 18, 2019
  • Applicant Novelion Therapeutics Inc.
  • Appointee Alvarez & Marsal Canada Inc.
  • Appointee role liquidator
  • Court Supreme Court of British Columbia
  • + 2 more extracted facts
PDF · Subscribers
Verified Petition & DeclarationPDF · Subscribers
First Affidavit of Michael Price made November 14, 2019PDF · Subscribers
Proof of ClaimPDF · Subscribers
Closing OrderPDF · Subscribers
Final Report and Petitioner’s MotionPDF · Subscribers
Motion for Ordering Enforcing the Final Distribution Order
  • Proceeding type foreign_ancillary
  • Statutory basis sections 105(a) and 1521 of the Bankruptcy Code
PDF · Subscribers
Notice MotionPDF · Subscribers
Provisional Relief MotionPDF · Subscribers
Recognition OrderPDF · Subscribers
Chap. 15 petitionPDF · Subscribers
Foreign DeclarationPDF · Subscribers
Notice of Application for the Interim DistributionPDF · Subscribers
Order Enforcing Final DistributionPDF · Subscribers
Order Made After Application (Interim Distribution)PDF · Subscribers

Filing titles and dates are public, and so is each filing's own page. The figures read from them are for subscribers.

CiteProceedings., “Novelion Therapeutics Inc.” (Winding-up (provincial)), Supreme Court of British Columbia. Retrieved 21 September 2026, https://proceedings.ca/case/novelion-therapeutics-inc

Sources last checked · record updated 31 August 2026 · Report a correction · Printed from proceedings.ca/case/novelion-therapeutics-inc

Facts and summaries are extracted automatically from the court filings linked on each page; the filings remain the authoritative record. Suggested corrections are reviewed against the source filings.